" " indicates required fields
A new CVE lands.
Your team already knows which products are affected.
Most teams spend days to weeks figuring out CVE impact. EVSec maps every new vulnerability to your specific products and components automatically, prioritizes by real risk, and triggers optimized remediation workflows without manual intervention.
0
Seconds
Auto
Cross-referencing CVE databases against component inventories takes days. By then, more CVEs have landed.
Generic CVSS scores do not tell you which vulnerabilities actually affect your products or matter to your customers.
Status updates, ownership, and audit trails scattered across emails and spreadsheets. No single view of what is fixed, in progress, or overdue.
VEX and VDR documents built by hand for every submission. No automated connection between your vulnerability data and your compliance outputs.
Generic scanners find vulnerabilities
EVSec tells you which ones actually matter
FDA 524B
ISO/SAE 21434
UN R155
EU CRA
IEC 62443
NIST SSDF
VEX
VDR
CycloneDX
Auto-ISAC ATM
DO-326A
AIS 189
IEC 81001-5-1
GB 44495-2024
"When a CVE is disclosed, the system manages it. We do not halt innovation to perform manual triage."
Tier 1 Automotive Supplier
CRO
C2A Security
VP and GM, Medical Technology
C2A Security
Ken Zalevsky brings over 20 years of medical device cybersecurity experience to his role at C2A Security, where he serves as VP and GM, Medical Technology, following the acquisition of Vigilant Ops in October 2025. A former Bayer executive, Ken founded Vigilant Ops in 2019 after witnessing the consequences of inadequate technical preparation in the healthcare industry. He is an active contributor to CISA’s SBOM working groups and a frequent speaker on software supply chain security. Ken’s mission: transform SBOM from a compliance checkbox into operational intelligence that keeps patients safe while streamlining regulatory processes.